Literature DB >> 8419082

Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis.

C T Da Costa1, S Khanolkar-Young, A M Elliott, K M Wasunna, K P McAdam.   

Abstract

Immunoglobulin G subclass responses to lipoarabinomannan (LAM) of Mycobacterium tuberculosis were determined by ELISA in both HIV-1 antibody positive (n = 31) and negative (n = 43) patients with tuberculosis (TB). Responses were also studied in a group of healthy controls (n = 16) and HIV-1 antibody positive (n = 60) individuals without TB. IgG2 antibodies were the predominant subclass, being present in 25 of 43 non-HIV-infected TB patients (58%) and in 11 of 31 HIV-infected TB patients (35%). However, HIV+ TB patients also showed IgG4 (n = 16; 52%), and IgG1 (n = 4, 13%) responses to LAM, whereas these subclasses were absent in sera from HIV-TB patients. Individuals in both non-tuberculous control groups showed no antibody responses to LAM. The influence of HIV infection on B cell responses to LAM, and possible mechanisms for antibody-mediated regulation of immunity to TB, are explored.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419082      PMCID: PMC1554641          DOI: 10.1111/j.1365-2249.1993.tb03348.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Authors:  R C Aalberse; R van der Gaag; J van Leeuwen
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

2.  Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age.

Authors:  M van der Giessen; E Rossouw; T A van Veen; E van Loghem; B J Zegers; P C Sander
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

3.  Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies.

Authors:  P Aucouturier; F Danon; M Daveau; B Guillou; A Sabbah; J Besson; J L Preud'homme
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

4.  Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children.

Authors:  A Freijd; L Hammarström; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

6.  A community survey of IgG4 antibody levels.

Authors:  J Merrett; M L Burr; T G Merrett
Journal:  Clin Allergy       Date:  1983-09

7.  Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo.

Authors:  H L Spiegelberg; R J Falkoff; R D O'Connor; L Beck
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

8.  Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida.

Authors:  A E Pitchenik; C Cole; B W Russell; M A Fischl; T J Spira; D E Snider
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

9.  Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome.

Authors:  P Aucouturier; L J Couderc; D Gouet; F Danon; J Gombert; S Matheron; A G Saimot; J P Clauvel; J L Preud'homme
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

10.  Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages.

Authors:  B Rynnel-Dagöö; A Freijd; L Hammarström; V Oxelius; M A Persson; C I Smith
Journal:  Acta Otolaryngol       Date:  1986 Jan-Feb       Impact factor: 1.494

View more
  19 in total

1.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Detection of anti-85A and anti-85B IgG antibodies in HIV-infected patients with active pulmonary tuberculosis.

Authors:  J P Van Vooren; P Launois; K Huygen; B Leguenno; A Drowart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

3.  Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study.

Authors:  K Boggian; W Fierz; P L Vernazza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

4.  IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients.

Authors:  A O Sousa; S Henry; F M Marója; F K Lee; L Brum; M Singh; P H Lagrange; P Aucouturier
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis.

Authors:  G Hetland; H G Wiker; K Høgåsen; B Hamasur; S B Svenson; M Harboe
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

6.  Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients.

Authors:  R Hussain; G Dawood; N Abrar; Z Toossi; A Minai; M Dojki; J J Ellner
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

7.  Age-dependent humoral responses of children to mycobacterial antigens.

Authors:  M P Fairchok; J H Rouse; S L Morris
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

8.  Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients.

Authors:  N Simonney; J M Molina; M Molimard; E Oksenhendler; C Perronne; P H Lagrange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

9.  Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan.

Authors:  Josephine Anne D Navoa; Suman Laal; Liise-Anne Pirofski; Gary R McLean; Zhongdong Dai; John B Robbins; Rachel Schneerson; Arturo Casadevall; Aharona Glatman-Freedman
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis.

Authors:  Farahnaz Movahedzadeh; Paul R Wheeler; Premkumar Dinadayala; Yossef Av-Gay; Tanya Parish; Mamadou Daffé; Neil G Stoker
Journal:  BMC Microbiol       Date:  2010-02-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.